Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

PHAR 350 > Polypharmacy and Deprescribing > Flashcards

Polypharmacy and Deprescribing Flashcards

1
Q

What is polypharmacy? (2 - 3+2)

A
  1. High number of meds
    - No universally agreed-upon cutoff
    - Literature supports 5 or more meds as being associated with increased risk
    - More than 10 meds = hyperpolypharmacy
  2. Lack of appropriateness of meds
    - Meds with no indication
    - Use of inappropriate meds
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

True or False? Under-utilization of meds is never an issue in older adults

A

False - common in older adults

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

List some meds/conditions that are not prescribed (under-utilization) (4)

A
  1. Bisphosphonates for osteoporosis
  2. Anticoagulation for afib
  3. Pain meds
  4. COPD treatment
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

The task for the clinician is not to determine whether too many or too few meds are being taken, but to determine if the patient is taking the _____ meds

A

right

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

__% age 65-74 taking 5+ meds
__% age 85+ taking 5+ meds

A

58
80

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Why are older adults using such a disproportionate amount of meds?

A

They tend to be a population that has 2 to 4+ chronic conditions which require meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Why should we be concerned about polypharmcy?

A

Number 1 risk factor for adverse drug reactions = number of medications taken

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Adverse drug reactions account for __-__% of hospitalization in older adults. Of which __% are considered preventable

A

10-30
65

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Older adults are particularly vulnerable to polypharmacy and ADRs because? (4)

A
  1. Altered medication response
  2. More comorbidities
  3. Altered homeostatic mechanisms
  4. Limited EBM
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are the 3 sections of the BEERS criteria that we should know?

A
  1. Medications generally considered inappropriate for older adults
    - Unfavorable risk/benefit profile + better alternatives available
    - e.g., first-gen antihistamines, warfarin
  2. Medications inappropriate for older adults with certain medical conditions
    - Drug-disease interactions
    - e.g., NSAIDs in HF
  3. Medications to be used with caution in older adults
    - Some evidence of potential harm, or increased monitoring required in older adults
    - E.g., dabigatran, prasugrel, ticagrelor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the utility of the BEERS criteria?

A

Useful tool to assist in identifying PIMs for older adults
- Identify medications that may warrant reevaluation or closer monitoring

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

While the BEERS criteria is a useful tool, what should we be aware of when optimizing medications? (2)

A
  1. Absence of a BEERS medication does not mean an older adult’s medications are optimized
  2. Most ADR-related hospitalizations in older adults are not due to BEERS drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What are the top 10 drug classes most commonly associated with seniors’ ADR-related hospitalizations?

A
  1. Anticoagulants
  2. Other antineoplastic drugs
  3. Opioids and related analgesics
  4. Glucocorticoids and synthetic analogues
  5. Beta-adrenoreceptor antagonists, not elsewhere classified
  6. NSAIDs (excluding salicylates)
  7. Loop (high-ceiling) diuretics
  8. Benzothiadiazine derivatives
  9. Other diuretics
  10. ACEis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What are explicit prescribing tools? (2)
What are the pros and cons?

A
  1. Usually consensus criteria developed by a panel of experts
  2. Lists of medications to either use or avoid
  3. Pros: Easy to use and implement
  4. Cons: Miss other types of DTPs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are implicit prescribing tools?
What are the pros and cons?

A
  1. Outline a process for the clinician to follow to identify DTPs
  2. Pros: Very comprehensive approach to identifying DTPs
  3. Cons: Require clinician knowledge/expertise, time-consuming
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Give 3 examples of explicit prescribing tools

A
  1. BEERS criteria
  2. STOPP/START criteria
  3. STOPP FRAIL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Give 2 examples of implicit prescribing tools

A
  1. Medication Appropriateness Index
  2. Good Palliative-Geriatric Practice Algorithm
18
Q

What is the Medication Appropriateness Index?

A
  1. Can be used as a research tool to evaluate a patient’s medication regimen
  2. More useful in clinical practice as a series of questions to ask
    - As part of a comprehensive medication review to assess the appropriateness of each drug
    - Before starting a new medication
19
Q

What is the problem with the Medication Appropriateness Index and the Good Palliative-Geriatric Practice Algorithm?

A

They do not help identify untreated conditions

20
Q

What is deprescribing?

A

The process of tapering, reducing, or stopping medications to improve clinical outcomes

21
Q

What are some common meds that have deprescribing guidelines associated with them? (4)

A
  1. PPIs
  2. BZDs and Z-drugs for insomnia
  3. Cholinesterase inhibitors for dementia
  4. Glyburide and other hypoglycemics
22
Q

The Canadian Deprescribing Network is developed patient information about the risks of certain medications. Such as? (7)

A
  1. NSAIDS
  2. Antipsychotics
  3. First-generation antihistamines
  4. Sulfonylureas like glyburide
  5. Opioids for chronic non-cancer pain
  6. Sleeping pills and anti-anxiety medications
  7. PPIs
23
Q

What are the 5 steps you should be going through when approaching polypharmacy?

A
  1. Identify patients at risk of/experiencing polypharmacy or adverse drug reactions
  2. Obtain an accurate medication history
    - Evaluate adherence to medications
  3. Are any symptoms or problems the patient is experiencing potentially caused or worsened by a drug they are taking?
    - Need to know medication’s pharmacology and side effects
    - Also need to consider the time of onset of symptoms in relation to starting the drug
  4. Match medical conditions with medications
  5. Align drug therapies with the patient’s goals and priorities
    - Life expectancy
    - Time to benefit of the med
    - Pt preferences
24
Q

What is time to benefit activity? (3)

A
  1. Refers to how long someone needs to take or be on a med before they’re likely to receive the anticipated benefit from it.
  2. Helps us evaluate appropriateness of different therapies within the context of how likely a particular patient is to receive benefit
  3. Geriatric meds towards people who are older and frailer
25
Q

What are 2 considerations for determining time to benefit?

A
  1. Patient’s individual risk of event
    - Secondary prevention will have greater magnitude of benefit (lower NNT) than primary prevention
  2. Clinical trial data
    - How long was the study?
    - When was impact of intervention seen?
26
Q

What are some tips for successful deprescribing? (5)

A
  1. Patient/caregiver buy-in is key
  2. Taper/stop one medication at a time if possible
  3. Watch for/try to break up prescribing cascades
  4. Consider whether any drug interactions may be unmasked when stopping a medication
  5. Anticipate and manage potential adverse drug withdrawal reactions
27
Q

What are adverse drug withdrawal reactions? (3)

A

Clinically significant signs or symptoms on discontinuing a drug
1. Physiologic withdrawal
2. Recurrence of underlying condition
3. Discontinuation symptoms

28
Q

When in doubt (for an ADWR) what should be done?

A

Taper a medication off slowly - particularly if on a higher dose and/or have been taking chronically

29
Q

What are the acute ADWRs seen with antidepressants (SSRIs, SNRIs, TCAs)? (4)

A
  1. Insomnia
  2. Agitation
  3. Sweating
  4. Malaise
30
Q

What is the chronic ADWRs seen with antideprssants?

A

Depression recurrence

31
Q

What are the ADWRs seen with hypnotics (BZDs, zopiclone, zalepon) (4)

A
  1. Rebound insomnia
  2. Agitation
  3. Anxiety
  4. Tremor
32
Q

What are the ADWRs seen with narcotics? (6)

A
  1. Increased pain
  2. Mobility changes
  3. Insomnia
  4. Agitation
  5. Anxiety
  6. Diarrhea
33
Q

What are the ADWRs seen with antipyschotics? (4)

A
  1. Hallucinations
  2. Restlessness
  3. Agitation
  4. Insomnia
34
Q

What are the ADWRs seen with beta-blockers? (3)

A
  1. Increased HR
  2. Increased BP
  3. Angina
35
Q

What are the ADWRs seen with digoxin? (2)

A
  1. Palpitations
  2. Increased HR
36
Q

What are the ADWRs seen with diuretics (furosemide, HCTZ)? (4)

A
  1. Increased BP
  2. Edema
  3. Weight gain
  4. SOB
37
Q

What are the ADWRs seen with PPIs/H2RAs? (3)

A
  1. Nausea
  2. Weakness
  3. Decreased BP
38
Q

What are the ADWRs seen with corticosteroids? (3)

A
  1. Nausea
  2. Weakness
  3. Decreased BP
39
Q

What are the ADWRs seen with anticholinergic agents? (5)

A
  1. Anxiety
  2. Nausea
  3. Vomiting
  4. Diarrhea
  5. Dizziness
40
Q

What are the ADWRs seen with antiparkinsonian agents? (3)

A
  1. Rigidity
  2. Tremor
  3. Hypotension
41
Q

What are some medications to know that are NOT associated with ADWRs? (5)

A
  1. Bisphosphonates and denosumab
  2. Aspirin
  3. Anticoagulants
  4. Statins
  5. Vitamin and mineral supplements

PHAR 350 (6 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions